Neuroendoscopic Devices Market Value, Volume, Share and Growth Strategies 2022-2032
The Neuroendoscopy Devices Market is expected to escalate at a CAGR of 7.6% from USD 165.0 Million in 2022 to USD 343.2 Million through 2032. COVID-19 has had a moderate impact on the neuroendoscopy market; these devices are used to treat conditions of the central nervous system, and as elective surgeries have been postponed, neuroendoscopy has been used less frequently than usual, resulting in a decrease in investment. Globally increasing brain tumour incidences and technological advancements in neuroendoscopic devices will drive the neuroendoscopic devices market forward. After delayed elective procedures are completed and vaccines are available, the neuroendoscope devices market is expected to perform well in 2021, as patients feel more confident about completing delayed screenings. According to the American Society of Clinical Oncology (ASCO), there were approximately 23,820 cases of brain tumours reported in the United States in 2019. Furthermore, brain tu...